Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000108

Director sold 1,666 shares at $29.60 ($49,314)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2023-07-17 Sale 10b5-1 −1,666 $29.60 $49,314 133,037 D
Open-market sales · 1,666 sh · avg $29.60 · $49,314
Loading xslF345X05/wk-form4_1689800946.xml…